🔎 Trials Near Me

Beranda › Kanker Paru › Ohio › Dayton

Uji klinis Kanker Paru di Dayton, OH

14 studi untuk Kanker Paru mencari peserta di lokasi sekitar Dayton (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • Miami Valley Hospital, Dayton
  • Dayton Physician LLC - Englewood, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 4 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Dayton Physician LLC - Englewood, Dayton
  • Greater Dayton Cancer Center, Kettering · 5 mi jauhnya
  • Kettering Medical Center, Kettering · 5 mi jauhnya
  • dan 4 lainnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Menerima pesertaFase 3
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 3 lainnya
Usia 70 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Menerima pesertaFase 3
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 4 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Menerima pesertaFase 3
  • Miami Valley Hospital, Dayton
  • Miami Valley Hospital North, Dayton
  • Miami Valley Hospital South, Centerville · 9 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06498635

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Menerima pesertaFase 2/3
  • Dayton Physicians Network, Dayton
  • Kettering Medical Center, Kettering · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06712316

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • Miami Valley Hospital South, Centerville · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Menerima pesertaFase 3
  • Kettering Medical Center, Kettering · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 3 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 4 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 3 lainnya
18 Minutes · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2/3
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 3 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06616584

Uji klinis Kanker Paru di kota lain

Studi lain di Dayton

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.